The Potential of Nanopore Sequencing Technology in Cancer Diagnosis

In this webinar, Mashiat Mimosa will discuss the potential of a new sequencing method that detects glioma tumors in brain tissue.

The Scientist Creative Services Team
May 11, 2022

This webinar will be hosted live and available on-demand

Thursday, June 16, 2022
11:00 AM Eastern Time (4 PM UK time)

Register Now

Fast, reliable diagnosis is crucial for treating cancer successfully. To diagnose gliomas in the central nervous system, scientists typically use next generation sequencing (NGS) to detect mutations in isocitrate dehydrogenase genes. In this webinar brought to you by Oxford Nanopore Technologies, Mashiat Mimosa will discuss the development and validation of a nanopore-based sequencing method for the potential molecular analysis of glioma.

Topics to be covered

  • The challenges posed by current NGS technologies used in isocitrate dehydrogenase mutational testing for glioma diagnosis
  • The optimization and validation of a nanopore-based single nucleotide variant detection assay

Register Now

Meet the Speaker:

Mashiat Mimosa
Graduate Student Researcher
University of Toronto
St. Michael’s Hospital


Sponsored by

Canopy